Cervical cancer screening & HPV vaccination: A comprehensive approach to cervical cancer control

Indian Journal of Medical Research

Volumn 130, Issue 3, 2009, Pages 241-246

  Basu, Partha ^a   Chowdhury, Debjani ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cervical cancer; HPV; HPV vaccine

Indexed keywords

ACETIC ACID; WART VIRUS VACCINE;

CANCER CONTROL; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ELECTROSURGERY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH EDUCATION; HUMAN; INDIA; MICROSCOPY; PAPANICOLAOU TEST; PRIMARY PREVENTION; PUBLIC HEALTH; REVIEW; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

COSTS AND COST ANALYSIS; FEMALE; HUMANS; INDIA; MASS SCREENING; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 72649102750     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, IARC Cancer Base No.5, version 2.0, Lyon: IARC Press; 2004.
2. Kitchener H, Castle PE, Cox JT. Achievements and limitations of cervical cytology screening. Vaccine 2006; 24S3: 63-70.
3. National Health Policy 2002. Ministry of Health & Family Welfare. Government of India. New Delhi. Available from: http://mohfw.nic.in/np2002.htm, accessed on August 11, 2009.
4. Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahé C, et al. Multicentre Study Group on Cervical Cancer Early Detection in India. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004; 11: 77-84.
5. Dabash R, Vajpayee J, Jacob M, Dzuba I, Lal N, Bradley I, et al. A Strategic Assessment of Cervical Cancer Prevention and Treatment Services in 3 Districts of Uttar Pradesh, India. Reprod Health 2005, 2: 11-8.
6. Government of India, Ministry of Health & Family Welfare. District cancer control. National cancer control program guidelines. New Delhi: Ministry of Health & Family Welfare; 2005.
7. Department of Cytology & Gynaecological Pathology. Postgraduate Institute of Medical Education and Research (PGIMER). Guidelines for cervical cancer screening programme. Government of India-World Health Organization Collaborative Programme (2004-2005). Chandigarh, India: PGIMER; 2006.
8. Juneja A, Sehgal A, Sharma S, Pandey A. Cervical cancer screening in India: The strategies revisited. Indian J Med Sci 2007; 61: 34-46.
9. Alliance for Cervical Cancer Prevention (ACCP). Effectiveness, safety and acceptance of cryotherapy: A systematic literature review. In: Cervical cancer prevention issues in depth 1. Seattle: ACCP; 2003.
10. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in lower source settings: clinical benefits and cost-effectiveness. JAMA 2001; 285: 3107-15.
11. Harper DM. Prophylactic human papilloma virus vaccines to prevent cervical cancer: Review of the Phase II and III trials. Therapy 2008; 5: 313-24.
12. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV 16/18 vaccine. Int J Cancer 2003; 106: 896-904.
13. Basu P, Sarkar S, Mukherjee S, Ghoshal M, Mittal S, Biswas S, et al. Women's perceptions and social barriers determine compliance to cervical screening: results from a population based study in India. Cancer Detect Prev 2006; 30: 369-74.
14. Villa LL. Prophylactic HPV-vaccines: Reducing the burden of HPV-related diseases. Vaccine 2006; 24S1: S1/23-8.
15. Bhatla N, Lal N, Bao Y, Ng T, Qiao YL. Human papillomavirus type-distribution in women from South Asia: A meta-analysis. Vaccine 2008; 26: 2811-7.
16. International Institute for Population Sciences (IIPS)and Macro International. National Family Health Survey (NFHS-3), 2005-06: India, vol. I. Mumbai: IPS; 2007.
17. Saxenian H, Hecht R. HPV vaccines: cost & financing. Proceedings of Stop Cervical Cancer: Accelerating Global Access to HPV Vaccines, December 12-13, 2006, London.
18. Batson A, Meheus F, Brooke S. Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine 2006; 24S3: 219-25.
19. Jacob M, Jeronimo J, Jumaan A. Need for synergy between strategies for cervical cancer prevention. Abstracts of the AOGIN India Biennial Conference. April 25-26, 2009, Kolkata.
20. Potential advanced market commitment investment, Vaccine-preventable disease information for expert committee: HPV vaccines. PATH & WHO for the World Bank & GAVI; 2006.
21. Diáz M, Kím JJ, Albero G, de anjose S, Clifford G, Boch Fx, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99: 230-8.